TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1
Thomas C. Pearson(Emory Healthcare), Christian P. Larsen(Emory University Hospital), Peter S. Linsley(Rosetta Stone (United States)), R P Lowry(Emory University), Kevin J. Winn(Emory University), Diane Z. Alexander(Emory University)
Cited by 298
Related Papers
CTLA-4 is a second receptor for the B cell activation antigen B7.
|The Journal of Experimental Medicine|1991|1.7k
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
|The Journal of Experimental Medicine|1997|802
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
|RNA|2006|785
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714